Generic Announced for Humalog
March 4, 2019 – Eli Lilly has announced that it will introduce a generic for its insulin product Humalog® (insulin lispro injection 100 units/mL) at a 50% discount to the current Humalog list price.
The announcement follows mounting pressure on drug companies regarding the high price of insulin in the United States. From 1996 to 2019, Humalog’s cost has increased 13-fold, from $21 to $275 per vial. According to Lilly, launching an authorized generic for Humalog offers a faster and more effective route to lowering patient costs than can be achieved through a list price reduction.
The list price of the new generic will be $137.35 per vial and $265.20 for a five-pack of pens. Lilly plans to make the product available to patients as soon as possible.